Cargando…
Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer
BACKGROUND: Phosphatase and tensin homolog (PTEN) is one of the most frequently inactivated tumor suppressors in breast cancer. While PTEN itself is not considered a druggable target, PTEN synthetic-sick or synthetic-lethal (PTEN-SSL) genes are potential drug targets in PTEN-deficient breast cancers...
Autores principales: | Tang, Yew Chung, Ho, Szu-Chi, Tan, Elisabeth, Ng, Alvin Wei Tian, McPherson, John R., Goh, Germaine Yen Lin, Teh, Bin Tean, Bard, Frederic, Rozen, Steven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863852/ https://www.ncbi.nlm.nih.gov/pubmed/29566768 http://dx.doi.org/10.1186/s13058-018-0949-3 |
Ejemplares similares
-
Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention
por: Poon, Song Ling, et al.
Publicado: (2014) -
In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors
por: Boot, Arnoud, et al.
Publicado: (2018) -
MSIseq: Software for Assessing Microsatellite Instability from Catalogs of Somatic Mutations
por: Ni Huang, Mi, et al.
Publicado: (2015) -
RNAi screening reveals a large signaling network controlling the Golgi apparatus in human cells
por: Chia, Joanne, et al.
Publicado: (2012) -
RNAi screening reveals a large signaling network controlling the Golgi apparatus in human cells
por: Chia, Joanne, et al.
Publicado: (2013)